Kentucky HB263 regulates the use of undesignated glucagon in schools for students with diabetes.
Kentucky HB263 establishes protocols for the use of undesignated glucagon in schools to manage severe hypoglycemia in students with diabetes. It requires school personnel to contact parents and emergency services when administering glucagon. The bill also mandates notification of school health providers, emergency services, and dispatch centers about the presence of glucagon in schools. It grants immunity from liability for those administering glucagon in good faith, except in cases of gross negligence or misconduct.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.